Amir Reichman
Directeur Général chez SCINAI IMMUNOTHERAPEUTICS LTD.
Fortune : - $ au 30/04/2024
Profil
Amir Reichman is the founder of NeuroDerm Ltd.
which was founded in 2003.
He was the Chief Engineer & Senior Scientist from 2003 to 2009.
Currently, he is the Chief Executive Officer & Director at Scinai Immunotherapeutics Ltd.
since 2021.
Previously, he worked at GlaxoSmithKline Pharmaceuticals SA (Belgium) as the Head-Global Vaccines Engineering Core Technology from 2015 to 2021 and at Novartis Vaccines & Diagnostics, Inc. (North Carolina) as the Head-Global Vaccines Value Chain Management from 2011 to 2015.
Mr. Reichman completed his undergraduate degree from Ben-Gurion University of the Negev and his MBA from The Wharton School of the University of Pennsylvania.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/03/2023 | 0 ( -.--% ) | - $ | 30/04/2024 |
Postes actifs de Amir Reichman
| Sociétés | Poste | Début |
|---|---|---|
| SCINAI IMMUNOTHERAPEUTICS LTD. | Directeur Général | 02/03/2021 |
Anciens postes connus de Amir Reichman
| Sociétés | Poste | Fin |
|---|---|---|
GlaxoSmithKline Pharmaceuticals SA (Belgium)
 GlaxoSmithKline Pharmaceuticals SA (Belgium) Pharmaceuticals: MajorHealth Technology GlaxoSmithKline Pharmaceuticals SA develops and manufactures pharmaceuticals and vaccines. The company is headquartered in Wavre, Belgium. | Corporate Officer/Principal | 01/03/2021 |
| Novartis Vaccines & Diagnostics, Inc. (North Carolina) | Corporate Officer/Principal | 01/01/2015 |
| NEURODERM LTD | Fondateur | 01/01/2009 |
Formation de Amir Reichman
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
| Ben-Gurion University of the Negev | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SCINAI IMMUNOTHERAPEUTICS LTD. | Health Technology |
| Entreprise privées | 3 |
|---|---|
GlaxoSmithKline Pharmaceuticals SA (Belgium)
GlaxoSmithKline Pharmaceuticals SA (Belgium) Pharmaceuticals: MajorHealth Technology GlaxoSmithKline Pharmaceuticals SA develops and manufactures pharmaceuticals and vaccines. The company is headquartered in Wavre, Belgium. | Health Technology |
| Novartis Vaccines & Diagnostics, Inc. (North Carolina) | |
NeuroDerm Ltd.
 NeuroDerm Ltd. BiotechnologyHealth Technology NeuroDerm Ltd. operates as a clinical-stage pharmaceutical company. It engages in the development of next-generation treatments for central nervous system disorders. The company was founded by Eliahu Heldman on March 18, 2003 and is headquartered in Rehovot, Israel. | Health Technology |
